These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 31059019

  • 1. Neuroprotective effects of lithium on a chronic MPTP mouse model of Parkinson's disease via regulation of α‑synuclein methylation.
    Zhao Q, Liu H, Cheng J, Zhu Y, Xiao Q, Bai Y, Tao J.
    Mol Med Rep; 2019 Jun; 19(6):4989-4997. PubMed ID: 31059019
    [Abstract] [Full Text] [Related]

  • 2. Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease.
    Katila N, Bhurtel S, Shadfar S, Srivastav S, Neupane S, Ojha U, Jeong GS, Choi DY.
    Neuropharmacology; 2017 Oct; 125():396-407. PubMed ID: 28807678
    [Abstract] [Full Text] [Related]

  • 3. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress.
    Zhu YL, Sun MF, Jia XB, Cheng K, Xu YD, Zhou ZL, Zhang PH, Qiao CM, Cui C, Chen X, Yang XS, Shen YQ.
    Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450
    [Abstract] [Full Text] [Related]

  • 4. Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson's disease and does not lead to a sustainable increase of brain-derived neurotrophic factor.
    Komnig D, Dagli TC, Habib P, Zeyen T, Schulz JB, Falkenburger BH.
    J Neurochem; 2018 Dec; 147(5):678-691. PubMed ID: 30152864
    [Abstract] [Full Text] [Related]

  • 5. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C, Rösler TW, de Andrade A, Oertel WH, Höglinger GU.
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Neuroprotective effect of crocin on substantia nigra in MPTP-induced Parkinson's disease model of mice.
    Haeri P, Mohammadipour A, Heidari Z, Ebrahimzadeh-Bideskan A.
    Anat Sci Int; 2019 Jan; 94(1):119-127. PubMed ID: 30159851
    [Abstract] [Full Text] [Related]

  • 8. Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson's disease.
    Zheng M, Liu C, Fan Y, Yan P, Shi D, Zhang Y.
    Neuropharmacology; 2017 Apr; 116():412-420. PubMed ID: 28093210
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Role of estrogen and levodopa in 1-methyl-4-pheny-l-1, 2, 3, 6-tetrahydropyridine (mptp)-induced cognitive deficit in Parkinsonian ovariectomized mice model: A comparative study.
    Yadav SK, Pandey S, Singh B.
    J Chem Neuroanat; 2017 Nov; 85():50-59. PubMed ID: 28711564
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ceftriaxone mediated rescue of nigral oxidative damage and motor deficits in MPTP model of Parkinson's disease in rats.
    Bisht R, Kaur B, Gupta H, Prakash A.
    Neurotoxicology; 2014 Sep; 44():71-9. PubMed ID: 25053526
    [Abstract] [Full Text] [Related]

  • 14. Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson's-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses.
    Lofrumento DD, Nicolardi G, Cianciulli A, De Nuccio F, La Pesa V, Carofiglio V, Dragone T, Calvello R, Panaro MA.
    Innate Immun; 2014 Apr; 20(3):249-60. PubMed ID: 23764428
    [Abstract] [Full Text] [Related]

  • 15. Possible role of propofol's cyclooxygenase-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an MPTP-induced murine model of Parkinson's disease.
    Kubo K, Inada T, Shingu K.
    Brain Res; 2011 Apr 28; 1387():125-33. PubMed ID: 21376018
    [Abstract] [Full Text] [Related]

  • 16. Soluble Epoxide Hydrolase Inhibition Attenuates MPTP-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System: Involvement of α-Synuclein Aggregation and ER Stress.
    Huang HJ, Wang YT, Lin HC, Lee YH, Lin AM.
    Mol Neurobiol; 2018 Jan 28; 55(1):138-144. PubMed ID: 28822080
    [Abstract] [Full Text] [Related]

  • 17. Ropinirole protects against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced neurotoxicity in mice via anti-apoptotic mechanism.
    Park G, Park YJ, Yang HO, Oh MS.
    Pharmacol Biochem Behav; 2013 Mar 28; 104():163-8. PubMed ID: 23369986
    [Abstract] [Full Text] [Related]

  • 18. Anti-inflammatory and anti-apoptotic effects of (RS)-glucoraphanin bioactivated with myrosinase in murine sub-acute and acute MPTP-induced Parkinson's disease.
    Galuppo M, Iori R, De Nicola GR, Bramanti P, Mazzon E.
    Bioorg Med Chem; 2013 Sep 01; 21(17):5532-47. PubMed ID: 23810671
    [Abstract] [Full Text] [Related]

  • 19. Protective action of recombinant neurturin on dopaminergic neurons in substantia nigra in a rhesus monkey model of Parkinson's disease.
    Li H, He Z, Su T, Ma Y, Lu S, Dai C, Sun M.
    Neurol Res; 2003 Apr 01; 25(3):263-7. PubMed ID: 12739234
    [Abstract] [Full Text] [Related]

  • 20. Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice.
    Patil SP, Jain PD, Ghumatkar PJ, Tambe R, Sathaye S.
    Neuroscience; 2014 Sep 26; 277():747-54. PubMed ID: 25108167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.